{"id":1977,"date":"2025-09-29T15:30:00","date_gmt":"2025-09-29T15:30:00","guid":{"rendered":"https:\/\/www.innothyrogen.eu\/uncategorized-hr\/innothyrogene-na-mld-konferenciji-u-sibeniku\/"},"modified":"2025-12-12T15:44:40","modified_gmt":"2025-12-12T15:44:40","slug":"innothyrogene-na-mld-konferenciji-u-sibeniku","status":"publish","type":"post","link":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/","title":{"rendered":"InnoThyroGene na MLD konferenciji u \u0160ibeniku"},"content":{"rendered":"\n

Unaprje\u0111enje laboratorijske dijagnostike kroz suradnju<\/strong><\/h2>\n\n

Dana 26. rujna 2025.<\/strong>, grad \u0160ibenik<\/strong> bio je doma\u0107in konferencije \u201cMLD: Od vizije do stvarnosti \u2013 Transformacija laboratorijske dijagnostike.\u201d<\/strong>Doga\u0111aj je okupio \u010dlanove MLD komore, zdravstvene djelatnike i predstavnike akademske zajednice.Fokus je bio na modernoj laboratorijskoj dijagnostici i njezinoj rastu\u0107oj ulozi u personaliziranoj medicini.<\/p>\n\n

Tijekom konferencije, nekoliko je stru\u010dnjaka predstavilo istra\u017eivanja usko povezana s projektom InnoThyroGene<\/strong>, isti\u010du\u0107i njegovu klini\u010dku relevantnost i znanstveni potencijal.<\/p>\n\n

Znanstveni program s InnoThyroGeneom<\/strong><\/h2>\n\n

Program je uklju\u010divao tri komplementarne prezentacije koje su se bavile genetikom, klini\u010dkom praksom i farmakoterapijom u bolestima \u0161titnja\u010de.Zajedno su ponudile sveobuhvatan pregled trenutnih izazova i novih rje\u0161enja u tom podru\u010dju.<\/p>\n\n

Prvo, prof. Tatijana Zemunik<\/a><\/strong> (MEFST<\/a>) odr\u017eala je pozvano predavanje pod naslovom \u201c\u0160to kontrolira na\u0161u \u0161titnja\u010du \u2013 genetika i\/ili okoli\u0161?\u201d<\/strong>U svom je govoru raspravljala o slo\u017eenoj interakciji izme\u0111u genetskih \u010dimbenika i utjecaja okoli\u0161a u regulaciji \u0161titnja\u010de.Nadalje, istaknula je va\u017enost razumijevanja tih mehanizama za pobolj\u0161anje dijagnostike i skrbi o pacijentima.<\/p>\n\n

Drugo, doc. dr. sc. Dubravka Brdar<\/a><\/strong> (KBC Split<\/a>) odr\u017eala je usmeno izlaganje pod naslovom \u201cUspostava biobanke pacijenata s bolestima \u0161titnja\u010de: Integracija laboratorijskih i klini\u010dkih podataka.\u201d<\/strong>Predstavila je prve rezultate projekta InnoThyroGene<\/strong>, obja\u0161njavaju\u0107i kako kombiniranje laboratorijskih nalaza s klini\u010dkim podacima podr\u017eava preciznija istra\u017eivanja i budu\u0107e klini\u010dke primjene.<\/p>\n\n

Kona\u010dno, Martina Domi\u0107, dr. med.<\/strong> (KBC Split) predstavila je poster pod naslovom \u201cFarmakoterapija i adherencija u pacijenata s bolestima \u0161titnja\u010de.\u201d<\/strong>Njezin rad ponudio je preliminarne uvide temeljene na podacima prikupljenim unutar biobanke InnoThyroGene.Uz to, istaknula je va\u017enost pridr\u017eavanja lije\u010denja za postizanje boljih ishoda u skrbi o \u0161titnja\u010di.<\/p>\n\n

Anga\u017eman publike i vidljivost projekta<\/strong><\/h2>\n\n

Tijekom sve tri prezentacije, projekt InnoThyroGene<\/strong> bio je jasno predstavljen.Kao rezultat toga, publika je pokazala sna\u017ean interes za ciljeve, metode i rane rezultate projekta.Nakon sesija, mnogi su sudionici pri\u0161li izlaga\u010dima, postavljaju\u0107i pitanja i nude\u0107i pozitivne povratne informacije.<\/p>\n\n

Ova aktivna anga\u017eiranost potvrdila je relevantnost projekta unutar profesionalne i akademske zajednice.<\/p>\n\n

Utjecaj InnoThyroGenea na MLD konferenciji u \u0160ibeniku<\/strong><\/h2>\n\n

Konferencija je donijela nekoliko va\u017enih rezultata za projekt:<\/p>\n\n

    \n
  • Pove\u0107ana vidljivost InnoThyroGenea<\/strong> me\u0111u zdravstvenim djelatnicima i akademicima<\/li>\n\n\n\n
  • Jasno predstavljanje klini\u010dkih i istra\u017eiva\u010dkih izazova kojima se projekt bavi<\/li>\n\n\n\n
  • Sna\u017ean interes za uspostavu i kori\u0161tenje biobanke bolesti \u0161titnja\u010de<\/li>\n\n\n\n
  • Pozitivne povratne informacije koje su potvrdile znanstvenu i prakti\u010dnu vrijednost projekta<\/li>\n\n\n\n
  • Nove prilike za budu\u0107u suradnju i razmjenu znanja<\/li>\n<\/ul>\n\n

    Posljedi\u010dno, InnoThyroGene na MLD konferenciji u \u0160ibeniku<\/strong> oja\u010dao je svoju poziciju relevantne inicijative u istra\u017eivanju bolesti \u0161titnja\u010de i laboratorijskoj dijagnostici.<\/p>\n\n

    Zaklju\u010dak<\/strong><\/h2>\n\n

    MLD konferencija u \u0160ibeniku pokazala je kako koordinirani klini\u010dki i istra\u017eiva\u010dki napori mogu podr\u017eati transformaciju laboratorijske dijagnostike.Predstavljanjem genetike, biobankarstva i farmakoterapije unutar jednog okvira, govornici su pokazali stvarnu vrijednost integriranih istra\u017eiva\u010dkih pristupa.Stoga je InnoThyroGene na MLD konferenciji u \u0160ibeniku<\/strong> pridonio unapre\u0111enju profesionalnog dijaloga i ja\u010danju dugoro\u010dnog utjecaja projekta.<\/p>\n\n

    Ostanite povezani<\/strong><\/h2>\n\n

    Za vi\u0161e novosti o znanstvenim doga\u0111anjima i projektnim aktivnostima, pratite InnoThyroGene<\/strong> na LinkedInu, X (Twitteru), Facebooku i Instagramu<\/strong>.<\/p>\n\n

    \n
    \"\"<\/figure>\n\n\n\n
    \"\"<\/figure>\n\n\n\n
    \"\"<\/figure>\n\n\n\n
    \"\"<\/figure>\n\n\n\n
    \"\"<\/figure>\n<\/figure>\n","protected":false},"excerpt":{"rendered":"

    Unaprje\u0111enje laboratorijske dijagnostike kroz suradnju Dana 26. rujna 2025., grad \u0160ibenik bio je doma\u0107in konferencije \u201cMLD: Od vizije do stvarnosti \u2013 Transformacija laboratorijske dijagnostike.\u201dDoga\u0111aj je okupio \u010dlanove MLD komore, zdravstvene djelatnike i predstavnike akademske zajednice.Fokus je bio na modernoj laboratorijskoj dijagnostici i njezinoj rastu\u0107oj ulozi u personaliziranoj medicini. Tijekom konferencije, nekoliko je stru\u010dnjaka predstavilo istra\u017eivanja […]<\/p>\n","protected":false},"author":1,"featured_media":1978,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[40],"tags":[43,41,42,45,60,44],"class_list":["post-1977","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti","tag-eufunded","tag-horizoneurope","tag-innothyrogen","tag-personalisedmedicine","tag-pharmacogenomics","tag-thyroidhealth"],"yoast_head":"\nInnoThyroGene na MLD konferenciji u \u0160ibeniku<\/title>\n<meta name=\"description\" content=\"InnoThyroGene na MLD konferenciji u \u0160ibeniku: Stru\u010dnjaci s MEFST-a i KBC-a Split predstavili su istra\u017eivanja o genetici, biobankarstvu i farmakoterapiji u bolestima \u0161titnja\u010de, ja\u010daju\u0107i vidljivost projekta i suradnju.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/\" \/>\n<meta property=\"og:locale\" content=\"hr_HR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"InnoThyroGene na MLD konferenciji u \u0160ibeniku\" \/>\n<meta property=\"og:description\" content=\"InnoThyroGene na MLD konferenciji u \u0160ibeniku: Stru\u010dnjaci s MEFST-a i KBC-a Split predstavili su istra\u017eivanja o genetici, biobankarstvu i farmakoterapiji u bolestima \u0161titnja\u010de, ja\u010daju\u0107i vidljivost projekta i suradnju.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/\" \/>\n<meta property=\"og:site_name\" content=\"InnoThyroGen EU projekt\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61571994011521\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-29T15:30:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-12T15:44:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/1758740920930.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@innothyrogenEU\" \/>\n<meta name=\"twitter:site\" content=\"@innothyrogenEU\" \/>\n<meta name=\"twitter:label1\" content=\"Napisao\/la\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Procijenjeno vrijeme \u010ditanja\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogene-na-mld-konferenciji-u-sibeniku\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogene-na-mld-konferenciji-u-sibeniku\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#\\\/schema\\\/person\\\/f6b134e97e8e2d2e2289a7953108188b\"},\"headline\":\"InnoThyroGene na MLD konferenciji u \u0160ibeniku\",\"datePublished\":\"2025-09-29T15:30:00+00:00\",\"dateModified\":\"2025-12-12T15:44:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogene-na-mld-konferenciji-u-sibeniku\\\/\"},\"wordCount\":532,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogene-na-mld-konferenciji-u-sibeniku\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/1758740920930.jpg\",\"keywords\":[\"#EUfunded\",\"#HorizonEurope\",\"#InnoThyroGen\",\"#Personalisedmedicine\",\"#Pharmacogenomics\",\"#ThyroidHealth\"],\"articleSection\":[\"Vijesti\"],\"inLanguage\":\"hr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogene-na-mld-konferenciji-u-sibeniku\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogene-na-mld-konferenciji-u-sibeniku\\\/\",\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogene-na-mld-konferenciji-u-sibeniku\\\/\",\"name\":\"InnoThyroGene na MLD konferenciji u \u0160ibeniku\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogene-na-mld-konferenciji-u-sibeniku\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogene-na-mld-konferenciji-u-sibeniku\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/1758740920930.jpg\",\"datePublished\":\"2025-09-29T15:30:00+00:00\",\"dateModified\":\"2025-12-12T15:44:40+00:00\",\"description\":\"InnoThyroGene na MLD konferenciji u \u0160ibeniku: Stru\u010dnjaci s MEFST-a i KBC-a Split predstavili su istra\u017eivanja o genetici, biobankarstvu i farmakoterapiji u bolestima \u0161titnja\u010de, ja\u010daju\u0107i vidljivost projekta i suradnju.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogene-na-mld-konferenciji-u-sibeniku\\\/#breadcrumb\"},\"inLanguage\":\"hr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogene-na-mld-konferenciji-u-sibeniku\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogene-na-mld-konferenciji-u-sibeniku\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/1758740920930.jpg\",\"contentUrl\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/1758740920930.jpg\",\"width\":1024,\"height\":683},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogene-na-mld-konferenciji-u-sibeniku\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Po\u010detna\",\"item\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"InnoThyroGene na MLD konferenciji u \u0160ibeniku\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#website\",\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/\",\"name\":\"InnoThyroGen EU Project\",\"description\":\"Inovacije u zdravlju \u0161titnja\u010de s genomikom i prediktivnim algoritmima kroz suradni\u010dku izvrsnost\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"hr\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#organization\",\"name\":\"InnoThyroGen EU projekt\",\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/logo_EMAIL_without_bacground_vertical.png\",\"contentUrl\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/logo_EMAIL_without_bacground_vertical.png\",\"width\":534,\"height\":520,\"caption\":\"InnoThyroGen EU projekt\"},\"image\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61571994011521\",\"https:\\\/\\\/x.com\\\/innothyrogenEU\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/innothyrogen-eu-project\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#\\\/schema\\\/person\\\/f6b134e97e8e2d2e2289a7953108188b\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/www.innothyrogen.eu\"],\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"InnoThyroGene na MLD konferenciji u \u0160ibeniku","description":"InnoThyroGene na MLD konferenciji u \u0160ibeniku: Stru\u010dnjaci s MEFST-a i KBC-a Split predstavili su istra\u017eivanja o genetici, biobankarstvu i farmakoterapiji u bolestima \u0161titnja\u010de, ja\u010daju\u0107i vidljivost projekta i suradnju.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/","og_locale":"hr_HR","og_type":"article","og_title":"InnoThyroGene na MLD konferenciji u \u0160ibeniku","og_description":"InnoThyroGene na MLD konferenciji u \u0160ibeniku: Stru\u010dnjaci s MEFST-a i KBC-a Split predstavili su istra\u017eivanja o genetici, biobankarstvu i farmakoterapiji u bolestima \u0161titnja\u010de, ja\u010daju\u0107i vidljivost projekta i suradnju.","og_url":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/","og_site_name":"InnoThyroGen EU projekt","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61571994011521","article_published_time":"2025-09-29T15:30:00+00:00","article_modified_time":"2025-12-12T15:44:40+00:00","og_image":[{"width":1024,"height":683,"url":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/1758740920930.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@innothyrogenEU","twitter_site":"@innothyrogenEU","twitter_misc":{"Napisao\/la":"admin","Procijenjeno vrijeme \u010ditanja":"3 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/#article","isPartOf":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/"},"author":{"name":"admin","@id":"https:\/\/www.innothyrogen.eu\/hr\/#\/schema\/person\/f6b134e97e8e2d2e2289a7953108188b"},"headline":"InnoThyroGene na MLD konferenciji u \u0160ibeniku","datePublished":"2025-09-29T15:30:00+00:00","dateModified":"2025-12-12T15:44:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/"},"wordCount":532,"commentCount":0,"publisher":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/#organization"},"image":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/#primaryimage"},"thumbnailUrl":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/1758740920930.jpg","keywords":["#EUfunded","#HorizonEurope","#InnoThyroGen","#Personalisedmedicine","#Pharmacogenomics","#ThyroidHealth"],"articleSection":["Vijesti"],"inLanguage":"hr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/","url":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/","name":"InnoThyroGene na MLD konferenciji u \u0160ibeniku","isPartOf":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/#primaryimage"},"image":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/#primaryimage"},"thumbnailUrl":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/1758740920930.jpg","datePublished":"2025-09-29T15:30:00+00:00","dateModified":"2025-12-12T15:44:40+00:00","description":"InnoThyroGene na MLD konferenciji u \u0160ibeniku: Stru\u010dnjaci s MEFST-a i KBC-a Split predstavili su istra\u017eivanja o genetici, biobankarstvu i farmakoterapiji u bolestima \u0161titnja\u010de, ja\u010daju\u0107i vidljivost projekta i suradnju.","breadcrumb":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/#breadcrumb"},"inLanguage":"hr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/"]}]},{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/#primaryimage","url":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/1758740920930.jpg","contentUrl":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/1758740920930.jpg","width":1024,"height":683},{"@type":"BreadcrumbList","@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogene-na-mld-konferenciji-u-sibeniku\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Po\u010detna","item":"https:\/\/www.innothyrogen.eu\/hr\/"},{"@type":"ListItem","position":2,"name":"InnoThyroGene na MLD konferenciji u \u0160ibeniku"}]},{"@type":"WebSite","@id":"https:\/\/www.innothyrogen.eu\/hr\/#website","url":"https:\/\/www.innothyrogen.eu\/hr\/","name":"InnoThyroGen EU Project","description":"Inovacije u zdravlju \u0161titnja\u010de s genomikom i prediktivnim algoritmima kroz suradni\u010dku izvrsnost","publisher":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.innothyrogen.eu\/hr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"hr"},{"@type":"Organization","@id":"https:\/\/www.innothyrogen.eu\/hr\/#organization","name":"InnoThyroGen EU projekt","url":"https:\/\/www.innothyrogen.eu\/hr\/","logo":{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.innothyrogen.eu\/hr\/#\/schema\/logo\/image\/","url":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/03\/logo_EMAIL_without_bacground_vertical.png","contentUrl":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/03\/logo_EMAIL_without_bacground_vertical.png","width":534,"height":520,"caption":"InnoThyroGen EU projekt"},"image":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61571994011521","https:\/\/x.com\/innothyrogenEU","https:\/\/www.linkedin.com\/company\/innothyrogen-eu-project\/"]},{"@type":"Person","@id":"https:\/\/www.innothyrogen.eu\/hr\/#\/schema\/person\/f6b134e97e8e2d2e2289a7953108188b","name":"admin","image":{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/secure.gravatar.com\/avatar\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/www.innothyrogen.eu"],"url":"https:\/\/www.innothyrogen.eu\/hr\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/posts\/1977","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/comments?post=1977"}],"version-history":[{"count":1,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/posts\/1977\/revisions"}],"predecessor-version":[{"id":1981,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/posts\/1977\/revisions\/1981"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/media\/1978"}],"wp:attachment":[{"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/media?parent=1977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/categories?post=1977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/tags?post=1977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}